(NASDAQ: HSIC) Henry Schein's forecast annual revenue growth rate of 3.41% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.69%.
Henry Schein's revenue in 2025 is $12,938,000,000.On average, 18 Wall Street analysts forecast HSIC's revenue for 2025 to be $1,571,743,898,257, with the lowest HSIC revenue forecast at $1,502,286,262,127, and the highest HSIC revenue forecast at $1,622,012,390,846. On average, 18 Wall Street analysts forecast HSIC's revenue for 2026 to be $1,624,249,162,179, with the lowest HSIC revenue forecast at $1,541,370,898,051, and the highest HSIC revenue forecast at $1,689,350,980,450.
In 2027, HSIC is forecast to generate $1,685,936,961,047 in revenue, with the lowest revenue forecast at $1,586,694,948,746 and the highest revenue forecast at $1,765,518,930,579.